Research & Education

Chemoradiation in Elderly Patients with Stage III NSCLC Improves Overall Survival

Elderly patients with stage III non-small cell lung cancer (NSCLC) showed improved overall survival (OS) when treated with chemoradiation (CRT) compared to definitive radiation (RT) alone.

Lung Cancer Clinical Trial Eligibility Criteria and Requirements Have Increased in Number and Complexity

Eligibility criteria continue to increase in number and complexity for lung cancer clinical trials.

Scientific Advances in Thoracic Oncology in 2016 Highlighted by the IASLC

DENVER – Capturing and summarizing the remarkable progress in lung cancer prevention, diagnosis, staging and treatment in 2016, the International Association for the Study of Lung Cancer (IASLC) announces the second annual publication of “Scientific Advances in Thoracic Oncology,” available online now and in the August 2017 issue of the IASLC’s Journal of Thoracic Oncology (JTO).

Treatment Improved 5-year Overall Survival in Elderly Patients with Early-Stage Esophageal Cancer

DENVER – Elderly patients with early-stage esophageal cancer that received treatment had an increased 5-year overall survival when compared to patients who received observation with no treatment.

Radiotherapy for Invasive Breast Cancer Increases the Risk of Second Primary Lung Cancer

East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.

Lower Incidence of Esophagitis in Elderly Lung Cancer Patients Undergoing Definitive Radiation Therapy

Elderly non-small cell lung cancer (NSCLC) patients undergoing definitive radiation have a lower incidence of esophagitis compared to younger patients and tolerate aggressive standard treatment regimens.

Pages